nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunarizine—CYP2A6—Ifosfamide—testicular cancer	0.268	0.318	CbGbCtD
Flunarizine—CYP2B6—Ifosfamide—testicular cancer	0.174	0.207	CbGbCtD
Flunarizine—CYP2C9—Ifosfamide—testicular cancer	0.0921	0.109	CbGbCtD
Flunarizine—CYP2B6—Cisplatin—testicular cancer	0.0848	0.101	CbGbCtD
Flunarizine—CYP2B6—Doxorubicin—testicular cancer	0.0568	0.0675	CbGbCtD
Flunarizine—CYP1A2—Etoposide—testicular cancer	0.0489	0.058	CbGbCtD
Flunarizine—CYP2C9—Cisplatin—testicular cancer	0.0448	0.0532	CbGbCtD
Flunarizine—CYP2D6—Vinblastine—testicular cancer	0.0447	0.0531	CbGbCtD
Flunarizine—CYP2D6—Doxorubicin—testicular cancer	0.0275	0.0326	CbGbCtD
Flunarizine—CALM2—semen—testicular cancer	0.0188	0.133	CbGeAlD
Flunarizine—CALM1—semen—testicular cancer	0.0187	0.133	CbGeAlD
Flunarizine—CACNA1I—testis—testicular cancer	0.00923	0.0656	CbGeAlD
Flunarizine—CACNA1H—seminal vesicle—testicular cancer	0.00794	0.0565	CbGeAlD
Flunarizine—CACNA1I—lymph node—testicular cancer	0.00669	0.0475	CbGeAlD
Flunarizine—CYP2A6—seminal vesicle—testicular cancer	0.00588	0.0418	CbGeAlD
Flunarizine—CACNA1H—gonad—testicular cancer	0.00574	0.0408	CbGeAlD
Flunarizine—CALM3—seminal vesicle—testicular cancer	0.00507	0.036	CbGeAlD
Flunarizine—CACNA1H—female gonad—testicular cancer	0.00466	0.0332	CbGeAlD
Flunarizine—CALM2—embryo—testicular cancer	0.00424	0.0301	CbGeAlD
Flunarizine—CALM1—embryo—testicular cancer	0.00422	0.03	CbGeAlD
Flunarizine—CACNA1H—testis—testicular cancer	0.00414	0.0294	CbGeAlD
Flunarizine—CALM2—seminal vesicle—testicular cancer	0.00398	0.0283	CbGeAlD
Flunarizine—CACNA1H—lymph node—testicular cancer	0.003	0.0213	CbGeAlD
Flunarizine—CALM3—female gonad—testicular cancer	0.00298	0.0212	CbGeAlD
Flunarizine—CALM2—gonad—testicular cancer	0.00288	0.0204	CbGeAlD
Flunarizine—CALM1—gonad—testicular cancer	0.00286	0.0204	CbGeAlD
Flunarizine—CALM3—testis—testicular cancer	0.00264	0.0188	CbGeAlD
Flunarizine—CALM2—female gonad—testicular cancer	0.00234	0.0166	CbGeAlD
Flunarizine—CALM1—female gonad—testicular cancer	0.00233	0.0165	CbGeAlD
Flunarizine—CYP2B6—gonad—testicular cancer	0.00214	0.0152	CbGeAlD
Flunarizine—CALM2—testis—testicular cancer	0.00207	0.0147	CbGeAlD
Flunarizine—CALM1—testis—testicular cancer	0.00206	0.0147	CbGeAlD
Flunarizine—CALM3—lymph node—testicular cancer	0.00191	0.0136	CbGeAlD
Flunarizine—CYP1A1—female gonad—testicular cancer	0.00179	0.0127	CbGeAlD
Flunarizine—HRH1—female gonad—testicular cancer	0.0017	0.0121	CbGeAlD
Flunarizine—CYP2B6—testis—testicular cancer	0.00154	0.011	CbGeAlD
Flunarizine—HRH1—testis—testicular cancer	0.00151	0.0107	CbGeAlD
Flunarizine—CALM2—lymph node—testicular cancer	0.0015	0.0107	CbGeAlD
Flunarizine—CALM1—lymph node—testicular cancer	0.0015	0.0106	CbGeAlD
Flunarizine—CYP2D6—female gonad—testicular cancer	0.00129	0.00918	CbGeAlD
Flunarizine—CYP1A1—lymph node—testicular cancer	0.00115	0.00817	CbGeAlD
Flunarizine—CYP2D6—testis—testicular cancer	0.00115	0.00814	CbGeAlD
Flunarizine—HRH1—lymph node—testicular cancer	0.00109	0.00776	CbGeAlD
Flunarizine—CALM1—Endochondral Ossification—FGFR3—testicular cancer	0.000119	0.00675	CbGpPWpGaD
Flunarizine—CALM2—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000118	0.00668	CbGpPWpGaD
Flunarizine—CALM1—Fc epsilon receptor (FCERI) signaling—BCL10—testicular cancer	0.000118	0.00668	CbGpPWpGaD
Flunarizine—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	0.000116	0.00655	CbGpPWpGaD
Flunarizine—CYP2B6—Biological oxidations—HPGDS—testicular cancer	0.000115	0.00651	CbGpPWpGaD
Flunarizine—CALM3—B Cell Activation—BCL10—testicular cancer	0.000113	0.00639	CbGpPWpGaD
Flunarizine—CALM1—B Cell Activation—BCL10—testicular cancer	0.000109	0.00618	CbGpPWpGaD
Flunarizine—CALM2—B Cell Activation—BCL10—testicular cancer	0.000109	0.00618	CbGpPWpGaD
Flunarizine—CYP1A1—Biological oxidations—HPGDS—testicular cancer	0.000106	0.00601	CbGpPWpGaD
Flunarizine—CACNA1G—Axon guidance—MMP2—testicular cancer	0.000106	0.006	CbGpPWpGaD
Flunarizine—CACNA1H—Axon guidance—MMP2—testicular cancer	0.000103	0.00582	CbGpPWpGaD
Flunarizine—CACNA1I—Developmental Biology—MMP2—testicular cancer	0.000103	0.00581	CbGpPWpGaD
Flunarizine—CALM3—Downstream signaling of activated FGFR—KITLG—testicular cancer	8.43e-05	0.00478	CbGpPWpGaD
Flunarizine—HRH1—GPCR downstream signaling—INSL3—testicular cancer	8.18e-05	0.00463	CbGpPWpGaD
Flunarizine—CALM2—Downstream signaling of activated FGFR—KITLG—testicular cancer	8.16e-05	0.00462	CbGpPWpGaD
Flunarizine—CALM1—Downstream signaling of activated FGFR—KITLG—testicular cancer	8.16e-05	0.00462	CbGpPWpGaD
Flunarizine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	7.98e-05	0.00452	CbGpPWpGaD
Flunarizine—CALM3—Downstream signal transduction—KITLG—testicular cancer	7.92e-05	0.00449	CbGpPWpGaD
Flunarizine—CYP2C9—Biological oxidations—HPGDS—testicular cancer	7.92e-05	0.00448	CbGpPWpGaD
Flunarizine—CALM3—Signaling by FGFR—KITLG—testicular cancer	7.89e-05	0.00447	CbGpPWpGaD
Flunarizine—CALM3—Signaling by ERBB2—KITLG—testicular cancer	7.85e-05	0.00445	CbGpPWpGaD
Flunarizine—CALM3—DAP12 signaling—KITLG—testicular cancer	7.81e-05	0.00442	CbGpPWpGaD
Flunarizine—CALM2—Downstream signal transduction—KITLG—testicular cancer	7.67e-05	0.00434	CbGpPWpGaD
Flunarizine—CALM1—Downstream signal transduction—KITLG—testicular cancer	7.67e-05	0.00434	CbGpPWpGaD
Flunarizine—CALM2—Signaling by FGFR—KITLG—testicular cancer	7.63e-05	0.00432	CbGpPWpGaD
Flunarizine—CALM1—Signaling by FGFR—KITLG—testicular cancer	7.63e-05	0.00432	CbGpPWpGaD
Flunarizine—CALM2—Signaling by ERBB2—KITLG—testicular cancer	7.59e-05	0.0043	CbGpPWpGaD
Flunarizine—CALM1—Signaling by ERBB2—KITLG—testicular cancer	7.59e-05	0.0043	CbGpPWpGaD
Flunarizine—CACNA1G—Developmental Biology—MMP2—testicular cancer	7.56e-05	0.00428	CbGpPWpGaD
Flunarizine—CALM2—DAP12 signaling—KITLG—testicular cancer	7.55e-05	0.00428	CbGpPWpGaD
Flunarizine—CALM1—DAP12 signaling—KITLG—testicular cancer	7.55e-05	0.00428	CbGpPWpGaD
Flunarizine—HRH1—Signaling by GPCR—INSL3—testicular cancer	7.43e-05	0.00421	CbGpPWpGaD
Flunarizine—CALM3—Signaling by FGFR in disease—KITLG—testicular cancer	7.35e-05	0.00416	CbGpPWpGaD
Flunarizine—CALM3—DAP12 interactions—KITLG—testicular cancer	7.35e-05	0.00416	CbGpPWpGaD
Flunarizine—CALM3—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	7.35e-05	0.00416	CbGpPWpGaD
Flunarizine—CACNA1H—Developmental Biology—MMP2—testicular cancer	7.32e-05	0.00415	CbGpPWpGaD
Flunarizine—CALM3—Signaling by EGFR—KITLG—testicular cancer	7.28e-05	0.00412	CbGpPWpGaD
Flunarizine—CALM3—Signaling by EGFR in Cancer—KITLG—testicular cancer	7.22e-05	0.00409	CbGpPWpGaD
Flunarizine—CALM3—Signaling by PDGF—KITLG—testicular cancer	7.18e-05	0.00407	CbGpPWpGaD
Flunarizine—CALM2—Signaling by FGFR in disease—KITLG—testicular cancer	7.11e-05	0.00403	CbGpPWpGaD
Flunarizine—CALM1—Signaling by FGFR in disease—KITLG—testicular cancer	7.11e-05	0.00403	CbGpPWpGaD
Flunarizine—CALM2—DAP12 interactions—KITLG—testicular cancer	7.11e-05	0.00403	CbGpPWpGaD
Flunarizine—CALM1—DAP12 interactions—KITLG—testicular cancer	7.11e-05	0.00403	CbGpPWpGaD
Flunarizine—CALM2—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	7.11e-05	0.00403	CbGpPWpGaD
Flunarizine—CALM1—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	7.11e-05	0.00403	CbGpPWpGaD
Flunarizine—CALM2—Signaling by EGFR—KITLG—testicular cancer	7.04e-05	0.00399	CbGpPWpGaD
Flunarizine—CALM1—Signaling by EGFR—KITLG—testicular cancer	7.04e-05	0.00399	CbGpPWpGaD
Flunarizine—CALM1—Signaling by EGFR in Cancer—KITLG—testicular cancer	6.98e-05	0.00395	CbGpPWpGaD
Flunarizine—CALM2—Signaling by EGFR in Cancer—KITLG—testicular cancer	6.98e-05	0.00395	CbGpPWpGaD
Flunarizine—CALM1—Signaling by PDGF—KITLG—testicular cancer	6.95e-05	0.00394	CbGpPWpGaD
Flunarizine—CALM2—Signaling by PDGF—KITLG—testicular cancer	6.95e-05	0.00394	CbGpPWpGaD
Flunarizine—CALM3—B Cell Activation—KITLG—testicular cancer	6.8e-05	0.00385	CbGpPWpGaD
Flunarizine—CYP1A2—Biological oxidations—HPGDS—testicular cancer	6.76e-05	0.00383	CbGpPWpGaD
Flunarizine—CALM2—B Cell Activation—KITLG—testicular cancer	6.58e-05	0.00373	CbGpPWpGaD
Flunarizine—CALM1—B Cell Activation—KITLG—testicular cancer	6.58e-05	0.00373	CbGpPWpGaD
Flunarizine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	6.54e-05	0.00371	CbGpPWpGaD
Flunarizine—CALM3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	6.51e-05	0.00369	CbGpPWpGaD
Flunarizine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	6.33e-05	0.00359	CbGpPWpGaD
Flunarizine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	6.33e-05	0.00359	CbGpPWpGaD
Flunarizine—CALM2—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	6.29e-05	0.00357	CbGpPWpGaD
Flunarizine—CALM1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	6.29e-05	0.00357	CbGpPWpGaD
Flunarizine—CALM3—Downstream signaling of activated FGFR—FGFR3—testicular cancer	6.27e-05	0.00355	CbGpPWpGaD
Flunarizine—CALM3—Signaling by GPCR—INSL3—testicular cancer	6.18e-05	0.0035	CbGpPWpGaD
Flunarizine—CALM3—Signaling by WNT in cancer—H2AFZ—testicular cancer	6.08e-05	0.00344	CbGpPWpGaD
Flunarizine—CALM1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	6.06e-05	0.00343	CbGpPWpGaD
Flunarizine—CALM2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	6.06e-05	0.00343	CbGpPWpGaD
Flunarizine—CALM2—Signaling by GPCR—INSL3—testicular cancer	5.98e-05	0.00339	CbGpPWpGaD
Flunarizine—CALM1—Signaling by GPCR—INSL3—testicular cancer	5.98e-05	0.00339	CbGpPWpGaD
Flunarizine—CALM3—Downstream signal transduction—FGFR3—testicular cancer	5.89e-05	0.00334	CbGpPWpGaD
Flunarizine—CALM2—Signaling by WNT in cancer—H2AFZ—testicular cancer	5.88e-05	0.00333	CbGpPWpGaD
Flunarizine—CALM1—Signaling by WNT in cancer—H2AFZ—testicular cancer	5.88e-05	0.00333	CbGpPWpGaD
Flunarizine—CALM3—Signaling by FGFR—FGFR3—testicular cancer	5.86e-05	0.00332	CbGpPWpGaD
Flunarizine—CALM3—Signaling by ERBB2—FGFR3—testicular cancer	5.83e-05	0.0033	CbGpPWpGaD
Flunarizine—CALM3—DAP12 signaling—FGFR3—testicular cancer	5.8e-05	0.00329	CbGpPWpGaD
Flunarizine—CALM3—Downstream signaling of activated FGFR—KIT—testicular cancer	5.75e-05	0.00326	CbGpPWpGaD
Flunarizine—CALM2—Downstream signal transduction—FGFR3—testicular cancer	5.7e-05	0.00323	CbGpPWpGaD
Flunarizine—CALM1—Downstream signal transduction—FGFR3—testicular cancer	5.7e-05	0.00323	CbGpPWpGaD
Flunarizine—CALM2—Signaling by FGFR—FGFR3—testicular cancer	5.67e-05	0.00321	CbGpPWpGaD
Flunarizine—CALM1—Signaling by FGFR—FGFR3—testicular cancer	5.67e-05	0.00321	CbGpPWpGaD
Flunarizine—CALM2—Signaling by ERBB2—FGFR3—testicular cancer	5.64e-05	0.0032	CbGpPWpGaD
Flunarizine—CALM1—Signaling by ERBB2—FGFR3—testicular cancer	5.64e-05	0.0032	CbGpPWpGaD
Flunarizine—CALM2—DAP12 signaling—FGFR3—testicular cancer	5.61e-05	0.00318	CbGpPWpGaD
Flunarizine—CALM1—DAP12 signaling—FGFR3—testicular cancer	5.61e-05	0.00318	CbGpPWpGaD
Flunarizine—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	5.57e-05	0.00315	CbGpPWpGaD
Flunarizine—CALM2—Downstream signaling of activated FGFR—KIT—testicular cancer	5.57e-05	0.00315	CbGpPWpGaD
Flunarizine—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	5.46e-05	0.00309	CbGpPWpGaD
Flunarizine—CALM3—DAP12 interactions—FGFR3—testicular cancer	5.46e-05	0.00309	CbGpPWpGaD
Flunarizine—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	5.46e-05	0.00309	CbGpPWpGaD
Flunarizine—CALM3—Signaling by EGFR—FGFR3—testicular cancer	5.41e-05	0.00307	CbGpPWpGaD
Flunarizine—CALM3—Downstream signal transduction—KIT—testicular cancer	5.41e-05	0.00306	CbGpPWpGaD
Flunarizine—CALM3—Signaling by FGFR—KIT—testicular cancer	5.38e-05	0.00305	CbGpPWpGaD
Flunarizine—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	5.36e-05	0.00304	CbGpPWpGaD
Flunarizine—CALM3—Signaling by ERBB2—KIT—testicular cancer	5.35e-05	0.00303	CbGpPWpGaD
Flunarizine—CALM3—Signaling by PDGF—FGFR3—testicular cancer	5.34e-05	0.00303	CbGpPWpGaD
Flunarizine—CALM3—DAP12 signaling—KIT—testicular cancer	5.33e-05	0.00302	CbGpPWpGaD
Flunarizine—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	5.28e-05	0.00299	CbGpPWpGaD
Flunarizine—CALM1—DAP12 interactions—FGFR3—testicular cancer	5.28e-05	0.00299	CbGpPWpGaD
Flunarizine—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	5.28e-05	0.00299	CbGpPWpGaD
Flunarizine—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	5.28e-05	0.00299	CbGpPWpGaD
Flunarizine—CALM2—DAP12 interactions—FGFR3—testicular cancer	5.28e-05	0.00299	CbGpPWpGaD
Flunarizine—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	5.28e-05	0.00299	CbGpPWpGaD
Flunarizine—CALM2—Signaling by EGFR—FGFR3—testicular cancer	5.23e-05	0.00297	CbGpPWpGaD
Flunarizine—CALM1—Signaling by EGFR—FGFR3—testicular cancer	5.23e-05	0.00297	CbGpPWpGaD
Flunarizine—CALM2—Downstream signal transduction—KIT—testicular cancer	5.23e-05	0.00296	CbGpPWpGaD
Flunarizine—CALM1—Downstream signal transduction—KIT—testicular cancer	5.23e-05	0.00296	CbGpPWpGaD
Flunarizine—CALM2—Signaling by FGFR—KIT—testicular cancer	5.21e-05	0.00295	CbGpPWpGaD
Flunarizine—CALM1—Signaling by FGFR—KIT—testicular cancer	5.21e-05	0.00295	CbGpPWpGaD
Flunarizine—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	5.19e-05	0.00294	CbGpPWpGaD
Flunarizine—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	5.19e-05	0.00294	CbGpPWpGaD
Flunarizine—CALM2—Signaling by ERBB2—KIT—testicular cancer	5.18e-05	0.00293	CbGpPWpGaD
Flunarizine—CALM1—Signaling by ERBB2—KIT—testicular cancer	5.18e-05	0.00293	CbGpPWpGaD
Flunarizine—CALM2—Signaling by PDGF—FGFR3—testicular cancer	5.17e-05	0.00293	CbGpPWpGaD
Flunarizine—CALM1—Signaling by PDGF—FGFR3—testicular cancer	5.17e-05	0.00293	CbGpPWpGaD
Flunarizine—CALM2—DAP12 signaling—KIT—testicular cancer	5.15e-05	0.00292	CbGpPWpGaD
Flunarizine—CALM1—DAP12 signaling—KIT—testicular cancer	5.15e-05	0.00292	CbGpPWpGaD
Flunarizine—CALM3—B Cell Activation—FGFR3—testicular cancer	5.05e-05	0.00286	CbGpPWpGaD
Flunarizine—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	5.01e-05	0.00284	CbGpPWpGaD
Flunarizine—CALM3—DAP12 interactions—KIT—testicular cancer	5.01e-05	0.00284	CbGpPWpGaD
Flunarizine—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	5.01e-05	0.00284	CbGpPWpGaD
Flunarizine—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	5.01e-05	0.00284	CbGpPWpGaD
Flunarizine—CALM3—Signaling by NGF—KITLG—testicular cancer	5e-05	0.00284	CbGpPWpGaD
Flunarizine—CALM3—Signaling by EGFR—KIT—testicular cancer	4.97e-05	0.00281	CbGpPWpGaD
Flunarizine—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	4.92e-05	0.00279	CbGpPWpGaD
Flunarizine—CALM3—Signaling by PDGF—KIT—testicular cancer	4.9e-05	0.00278	CbGpPWpGaD
Flunarizine—CALM1—B Cell Activation—FGFR3—testicular cancer	4.89e-05	0.00277	CbGpPWpGaD
Flunarizine—CALM2—B Cell Activation—FGFR3—testicular cancer	4.89e-05	0.00277	CbGpPWpGaD
Flunarizine—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	4.85e-05	0.00275	CbGpPWpGaD
Flunarizine—CALM2—DAP12 interactions—KIT—testicular cancer	4.85e-05	0.00275	CbGpPWpGaD
Flunarizine—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	4.85e-05	0.00275	CbGpPWpGaD
Flunarizine—CALM1—DAP12 interactions—KIT—testicular cancer	4.85e-05	0.00275	CbGpPWpGaD
Flunarizine—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	4.85e-05	0.00275	CbGpPWpGaD
Flunarizine—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	4.85e-05	0.00275	CbGpPWpGaD
Flunarizine—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	4.85e-05	0.00275	CbGpPWpGaD
Flunarizine—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	4.85e-05	0.00275	CbGpPWpGaD
Flunarizine—CALM1—Signaling by NGF—KITLG—testicular cancer	4.84e-05	0.00274	CbGpPWpGaD
Flunarizine—CALM2—Signaling by NGF—KITLG—testicular cancer	4.84e-05	0.00274	CbGpPWpGaD
Flunarizine—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	4.84e-05	0.00274	CbGpPWpGaD
Flunarizine—CALM2—Signaling by EGFR—KIT—testicular cancer	4.81e-05	0.00272	CbGpPWpGaD
Flunarizine—CALM1—Signaling by EGFR—KIT—testicular cancer	4.81e-05	0.00272	CbGpPWpGaD
Flunarizine—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	4.76e-05	0.0027	CbGpPWpGaD
Flunarizine—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	4.76e-05	0.0027	CbGpPWpGaD
Flunarizine—CALM2—Signaling by PDGF—KIT—testicular cancer	4.74e-05	0.00269	CbGpPWpGaD
Flunarizine—CALM1—Signaling by PDGF—KIT—testicular cancer	4.74e-05	0.00269	CbGpPWpGaD
Flunarizine—CALM3—Innate Immune System—BCL10—testicular cancer	4.73e-05	0.00268	CbGpPWpGaD
Flunarizine—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	4.68e-05	0.00265	CbGpPWpGaD
Flunarizine—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	4.68e-05	0.00265	CbGpPWpGaD
Flunarizine—CALM3—B Cell Activation—KIT—testicular cancer	4.64e-05	0.00263	CbGpPWpGaD
Flunarizine—CALM2—Innate Immune System—BCL10—testicular cancer	4.58e-05	0.00259	CbGpPWpGaD
Flunarizine—CALM1—Innate Immune System—BCL10—testicular cancer	4.58e-05	0.00259	CbGpPWpGaD
Flunarizine—CALM3—Adaptive Immune System—BCL10—testicular cancer	4.55e-05	0.00258	CbGpPWpGaD
Flunarizine—CALM2—B Cell Activation—KIT—testicular cancer	4.49e-05	0.00254	CbGpPWpGaD
Flunarizine—CALM1—B Cell Activation—KIT—testicular cancer	4.49e-05	0.00254	CbGpPWpGaD
Flunarizine—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	4.44e-05	0.00252	CbGpPWpGaD
Flunarizine—CALM2—Adaptive Immune System—BCL10—testicular cancer	4.4e-05	0.00249	CbGpPWpGaD
Flunarizine—CALM1—Adaptive Immune System—BCL10—testicular cancer	4.4e-05	0.00249	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—INSL3—testicular cancer	4.39e-05	0.00249	CbGpPWpGaD
Flunarizine—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	4.29e-05	0.00243	CbGpPWpGaD
Flunarizine—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	4.29e-05	0.00243	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.07e-05	0.00231	CbGpPWpGaD
Flunarizine—CALM3—Signaling by NGF—FGFR3—testicular cancer	3.72e-05	0.00211	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—INSL3—testicular cancer	3.65e-05	0.00207	CbGpPWpGaD
Flunarizine—CALM1—Signaling by NGF—FGFR3—testicular cancer	3.6e-05	0.00204	CbGpPWpGaD
Flunarizine—CALM2—Signaling by NGF—FGFR3—testicular cancer	3.6e-05	0.00204	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—INSL3—testicular cancer	3.53e-05	0.002	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—INSL3—testicular cancer	3.53e-05	0.002	CbGpPWpGaD
Flunarizine—CALM3—Signaling by NGF—KIT—testicular cancer	3.41e-05	0.00193	CbGpPWpGaD
Flunarizine—CALM2—Signaling by NGF—KIT—testicular cancer	3.3e-05	0.00187	CbGpPWpGaD
Flunarizine—CALM1—Signaling by NGF—KIT—testicular cancer	3.3e-05	0.00187	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.04e-05	0.00172	CbGpPWpGaD
Flunarizine—CALM3—Innate Immune System—KITLG—testicular cancer	2.85e-05	0.00162	CbGpPWpGaD
Flunarizine—CALM2—Innate Immune System—KITLG—testicular cancer	2.76e-05	0.00156	CbGpPWpGaD
Flunarizine—CALM1—Innate Immune System—KITLG—testicular cancer	2.76e-05	0.00156	CbGpPWpGaD
Flunarizine—CALM3—Immune System—BCL10—testicular cancer	2.76e-05	0.00156	CbGpPWpGaD
Flunarizine—CALM3—Adaptive Immune System—KITLG—testicular cancer	2.74e-05	0.00155	CbGpPWpGaD
Flunarizine—CALM2—Immune System—BCL10—testicular cancer	2.67e-05	0.00151	CbGpPWpGaD
Flunarizine—CALM1—Immune System—BCL10—testicular cancer	2.67e-05	0.00151	CbGpPWpGaD
Flunarizine—CALM1—Adaptive Immune System—KITLG—testicular cancer	2.65e-05	0.0015	CbGpPWpGaD
Flunarizine—CALM2—Adaptive Immune System—KITLG—testicular cancer	2.65e-05	0.0015	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.6e-05	0.00147	CbGpPWpGaD
Flunarizine—CYP2A6—Metabolism—HPGDS—testicular cancer	2.44e-05	0.00138	CbGpPWpGaD
Flunarizine—CALM3—Innate Immune System—FGFR3—testicular cancer	2.12e-05	0.0012	CbGpPWpGaD
Flunarizine—CALM2—Innate Immune System—FGFR3—testicular cancer	2.05e-05	0.00116	CbGpPWpGaD
Flunarizine—CALM1—Innate Immune System—FGFR3—testicular cancer	2.05e-05	0.00116	CbGpPWpGaD
Flunarizine—CALM3—Adaptive Immune System—FGFR3—testicular cancer	2.04e-05	0.00115	CbGpPWpGaD
Flunarizine—CALM2—Adaptive Immune System—FGFR3—testicular cancer	1.97e-05	0.00112	CbGpPWpGaD
Flunarizine—CALM1—Adaptive Immune System—FGFR3—testicular cancer	1.97e-05	0.00112	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—HPGDS—testicular cancer	1.96e-05	0.00111	CbGpPWpGaD
Flunarizine—CALM3—Innate Immune System—KIT—testicular cancer	1.95e-05	0.0011	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—HPGDS—testicular cancer	1.91e-05	0.00108	CbGpPWpGaD
Flunarizine—CALM2—Innate Immune System—KIT—testicular cancer	1.88e-05	0.00107	CbGpPWpGaD
Flunarizine—CALM1—Innate Immune System—KIT—testicular cancer	1.88e-05	0.00107	CbGpPWpGaD
Flunarizine—CALM3—Adaptive Immune System—KIT—testicular cancer	1.87e-05	0.00106	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—HPGDS—testicular cancer	1.85e-05	0.00105	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—HPGDS—testicular cancer	1.85e-05	0.00105	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—HPGDS—testicular cancer	1.81e-05	0.00103	CbGpPWpGaD
Flunarizine—CALM2—Adaptive Immune System—KIT—testicular cancer	1.81e-05	0.00102	CbGpPWpGaD
Flunarizine—CALM1—Adaptive Immune System—KIT—testicular cancer	1.81e-05	0.00102	CbGpPWpGaD
Flunarizine—CYP2A6—Metabolism—STK11—testicular cancer	1.77e-05	0.001	CbGpPWpGaD
Flunarizine—CALM3—Disease—H2AFZ—testicular cancer	1.67e-05	0.000945	CbGpPWpGaD
Flunarizine—CALM3—Immune System—KITLG—testicular cancer	1.66e-05	0.000942	CbGpPWpGaD
Flunarizine—CALM2—Disease—H2AFZ—testicular cancer	1.61e-05	0.000914	CbGpPWpGaD
Flunarizine—CALM1—Disease—H2AFZ—testicular cancer	1.61e-05	0.000914	CbGpPWpGaD
Flunarizine—CALM1—Immune System—KITLG—testicular cancer	1.61e-05	0.000911	CbGpPWpGaD
Flunarizine—CALM2—Immune System—KITLG—testicular cancer	1.61e-05	0.000911	CbGpPWpGaD
Flunarizine—CALM3—Disease—KITLG—testicular cancer	1.53e-05	0.00087	CbGpPWpGaD
Flunarizine—CALM2—Disease—KITLG—testicular cancer	1.48e-05	0.000841	CbGpPWpGaD
Flunarizine—CALM1—Disease—KITLG—testicular cancer	1.48e-05	0.000841	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—STK11—testicular cancer	1.43e-05	0.000809	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—H2AFZ—testicular cancer	1.4e-05	0.000796	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—STK11—testicular cancer	1.4e-05	0.000791	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—STK11—testicular cancer	1.39e-05	0.000787	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—HPGDS—testicular cancer	1.37e-05	0.000774	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—HPGDS—testicular cancer	1.35e-05	0.000767	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—STK11—testicular cancer	1.34e-05	0.000761	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—STK11—testicular cancer	1.34e-05	0.000761	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—STK11—testicular cancer	1.32e-05	0.000747	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—KITLG—testicular cancer	1.29e-05	0.000732	CbGpPWpGaD
Flunarizine—CALM3—Immune System—FGFR3—testicular cancer	1.24e-05	0.0007	CbGpPWpGaD
Flunarizine—CALM2—Immune System—FGFR3—testicular cancer	1.2e-05	0.000677	CbGpPWpGaD
Flunarizine—CALM1—Immune System—FGFR3—testicular cancer	1.2e-05	0.000677	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—H2AFZ—testicular cancer	1.17e-05	0.000662	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—STK11—testicular cancer	1.16e-05	0.000658	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—HPGDS—testicular cancer	1.16e-05	0.000655	CbGpPWpGaD
Flunarizine—CALM3—Disease—FGFR3—testicular cancer	1.14e-05	0.000646	CbGpPWpGaD
Flunarizine—CALM3—Immune System—KIT—testicular cancer	1.13e-05	0.000643	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—H2AFZ—testicular cancer	1.13e-05	0.00064	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—H2AFZ—testicular cancer	1.13e-05	0.00064	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—STK11—testicular cancer	1.12e-05	0.000637	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—STK11—testicular cancer	1.12e-05	0.000637	CbGpPWpGaD
Flunarizine—CALM2—Disease—FGFR3—testicular cancer	1.1e-05	0.000625	CbGpPWpGaD
Flunarizine—CALM1—Disease—FGFR3—testicular cancer	1.1e-05	0.000625	CbGpPWpGaD
Flunarizine—CALM2—Immune System—KIT—testicular cancer	1.1e-05	0.000622	CbGpPWpGaD
Flunarizine—CALM1—Immune System—KIT—testicular cancer	1.1e-05	0.000622	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—KITLG—testicular cancer	1.07e-05	0.000609	CbGpPWpGaD
Flunarizine—CALM3—Disease—KIT—testicular cancer	1.05e-05	0.000593	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—KITLG—testicular cancer	1.04e-05	0.000589	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—KITLG—testicular cancer	1.04e-05	0.000589	CbGpPWpGaD
Flunarizine—CALM2—Disease—KIT—testicular cancer	1.01e-05	0.000574	CbGpPWpGaD
Flunarizine—CALM1—Disease—KIT—testicular cancer	1.01e-05	0.000574	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—STK11—testicular cancer	9.92e-06	0.000562	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—STK11—testicular cancer	9.84e-06	0.000557	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—FGFR3—testicular cancer	9.6e-06	0.000544	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—KIT—testicular cancer	8.82e-06	0.000499	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—STK11—testicular cancer	8.41e-06	0.000476	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—FGFR3—testicular cancer	7.99e-06	0.000453	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—FGFR3—testicular cancer	7.73e-06	0.000438	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—FGFR3—testicular cancer	7.73e-06	0.000438	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—KIT—testicular cancer	7.33e-06	0.000416	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—KIT—testicular cancer	7.1e-06	0.000402	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—KIT—testicular cancer	7.1e-06	0.000402	CbGpPWpGaD
